PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt

Author:

Uche Uzodinma U.12ORCID,Piccirillo Ann R.1,Kataoka Shunsuke3,Grebinoski Stephanie J.4,D’Cruz Louise M.1ORCID,Kane Lawrence P.1ORCID

Affiliation:

1. Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA

2. Interdisciplinary Biomedical Graduate Program, University of Pittsburgh School of Medicine, Pittsburgh, PA

3. Asahi Kasei Pharma Corporation, Tokyo, Japan

4. Graduate Program in Microbiology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA

Abstract

Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease and cancer. PIK3IP1 (or transmembrane inhibitor of PI3K [TrIP]) is a putative transmembrane regulator of PI3K. TrIP contains an extracellular kringle domain and an intracellular domain with homology to the inter-SH2 domain of the PI3K regulatory subunit p85, but the mechanism of TrIP function is poorly understood. We show that both the kringle and p85-like domains are necessary for TrIP inhibition of PI3K and that TrIP is down-modulated from the surface of T cells during T cell activation. In addition, we present evidence that the kringle domain may modulate TrIP function by mediating oligomerization. Using an inducible knockout mouse model, we show that TrIP-deficient T cells exhibit more robust activation and can mediate clearance of Listeria monocytogenes infection faster than WT mice. Thus, TrIP is a negative regulator of T cell activation and may represent a novel target for immune modulation.

Funder

Public Health Service

PHS

University of Pittsburgh

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

Reference45 articles.

1. INPP4B: the new kid on the PI3K block;Agoulnik;Oncotarget.,2011

2. SHIP is required for dendritic cell maturation;Antignano;J. Immunol.,2010

3. The phosphoinositide 3-kinase pathway;Cantley;Science.,2002

4. Kringle structures and antiangiogenesis;Cao;Curr. Med. Chem. Anticancer Agents.,2002

5. The PTEN-PI3K pathway: of feedbacks and cross-talks;Carracedo;Oncogene.,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3